In conclusion, our study demonstrates a significant correlation between hs-CRP and HbA1c levels in patients with AMI and T2DM, with both biomarkers being strong predictors of six-month morbidity and mortality. This evidence concerns the gene CRP and type 2 diabetes mellitus.